VIM and head and neck squamous cell carcinoma: These disregulated genes such as loss of E-cadherin and gain of vimentin have been identified as predictive marker for high-risk HNSCC tumours such as gefitinib resistance, but it remains unclear whether overexpression of EMT-associated genes are directly responsible for gefitinib resistance.